A 2026 UK review of the February 2025 Nature Aging DO-HEALTH trial (1 g/day slowed biological ageing ~4 months), the Framingham red-blood-cell DHA data (~49% lower Alzheimers risk in the top group), the midlife hippocampal-volume study, the ~20% lower dementia risk from dietary omega-3, the APOE4 timing question and the honest atrial-fibrillation caveat with high-dose fish oil versus Dihexas unproven HGF/c-Met synaptogenesis, and why oily fish comes first, not a peptide Read the full review NewNutrition, Diet & Cognitive Neuroscience 4 July 2026 Dihexa for Ultra-Processed Food Brain Fog: UPF, Cognition & the HGF/c-Met Question Can Dihexa undo ultra-processed food brain fog
Intranasal formulations of cyanocobalamin are not suitable for vitamin B12 absorption test (Schilling Test)
A systems-approach to NAD+ restoration
Overall, a new era in obesity care is starting, as multiple effective obesity pharmacotherapies with different mechanisms of action and routes of administration may become available over next years
Tirzepatide, by contrast, adds the GIP pathway within the same molecule: it co-activates the GIP receptor, a mechanism entirely absent from CagriSema
